Krebs FC - Search Results

1

Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.

Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Catalone BJ, et al. Among authors: krebs fc. Biomed Pharmacother. 2005 Sep;59(8):430-7. doi: 10.1016/j.biopha.2005.07.008. Biomed Pharmacother. 2005. PMID: 16154721

2

Neuroglial-specific factors and the regulation of retrovirus transcription.

Tillmann M, Krebs FC, Wessner R, Pomeroy SM, Goodenow MM, Wigdahl B. Tillmann M, et al. Among authors: krebs fc. Adv Neuroimmunol. 1994;4(3):305-18. doi: 10.1016/s0960-5428(06)80271-8. Adv Neuroimmunol. 1994. PMID: 7874399 Review.

3

Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.

Kenny JJ, Krebs FC, Hartle HT, Gartner AE, Chatton B, Leiden JM, Hoeffler JP, Weber PC, Wigdahl B. Kenny JJ, et al. Among authors: krebs fc. Virology. 1994 Apr;200(1):220-35. doi: 10.1006/viro.1994.1180. Virology. 1994. PMID: 8128624

4

Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat.

Krebs FC, Goodenow MM, Wigdahl B. Krebs FC, et al. J Neurovirol. 1997 May;3 Suppl 1:S28-32. J Neurovirol. 1997. PMID: 9179787 Review. No abstract available.

5

Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.

Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B. Krebs FC, et al. J Biomed Sci. 1998;5(1):31-44. doi: 10.1007/BF02253354. J Biomed Sci. 1998. PMID: 9570512

6

Millhouse S, Krebs FC, Yao J, McAllister JJ, Conner J, Ross H, Wigdahl B. Millhouse S, et al. Among authors: krebs fc. J Neurovirol. 1998 Jun;4(3):312-23. doi: 10.3109/13550289809114532. J Neurovirol. 1998. PMID: 9639074

7

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Howett MK, Neely EB, Christensen ND, Wigdahl B, Krebs FC, Malamud D, Patrick SD, Pickel MD, Welsh PA, Reed CA, Ward MG, Budgeon LR, Kreider JW. Howett MK, et al. Among authors: krebs fc. Antimicrob Agents Chemother. 1999 Feb;43(2):314-21. doi: 10.1128/AAC.43.2.314. Antimicrob Agents Chemother. 1999. PMID: 9925525 Free PMC article.

8

Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.

Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Krebs FC, et al. Antiviral Res. 1999 Oct;43(3):157-73. doi: 10.1016/s0166-3542(99)00044-3. Antiviral Res. 1999. PMID: 10551374

9

Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.

Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B. Krebs FC, et al. Antimicrob Agents Chemother. 2000 Jul;44(7):1954-60. doi: 10.1128/AAC.44.7.1954-1960.2000. Antimicrob Agents Chemother. 2000. PMID: 10858360 Free PMC article.

10

HIV-1-associated central nervous system dysfunction.

Krebs FC, Ross H, McAllister J, Wigdahl B. Krebs FC, et al. Adv Pharmacol. 2000;49:315-85. doi: 10.1016/s1054-3589(00)49031-9. Adv Pharmacol. 2000. PMID: 11013768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page